Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials

The Changing Role of mTOR Kinase in the Maintenance of Protein Synthesis during Human Cytomegalovirus Infection

(2011) A. J. Clippinger et al.   JOURNAL OF VIROLOGY

Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

(2010) I. Helanterä et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients

(2010) H. Tedesco Silva Jr. et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies

(2010) Tomáš Reischig   Expert Review of Anti-Infective Therapy

Rapamycin-Resistant mTORC1 Kinase Activity Is Required for Herpesvirus Replication

(2010) N. J. Moorman et al.   JOURNAL OF VIROLOGY

Immunosuppressive therapy and infection after kidney transplantation

(2010) J. Fortun et al.   Transplant Infectious Disease

Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial

(2010) Markus Guba et al.   TRANSPLANTATION

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil inde novocardiac transplant recipients: a randomized, multicenter study

(2009) M. Viganò et al.   Transplant Infectious Disease

Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis

(2009) Tomáš Reischig et al.   TRANSPLANTATION

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

(2008) S. K. Arthurs et al.   CLINICAL INFECTIOUS DISEASES

Use of Everolimus in De Novo Renal Recipients: Initial Experience in the Greek Population

(2008) V. Papanikolaou et al.   TRANSPLANTATION PROCEEDINGS

Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials

(2008) L. Demopoulos et al.   TRANSPLANTATION PROCEEDINGS